Companies: 10,795·Total market cap: $144.5T
Nemaura Medical Inc.

Nemaura Medical Inc.

NMRDOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8070
P/E Ratio—
52W High$0.0005
52W Low$0.00001
Overview

Nemaura Medical Inc. (NMRD) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001602078 · NMRD · OTC · as of Jun 9, 2026

Filing snapshot

276
Total Filings
8-K
Latest Form
2024-09-26
Most Recent
2018
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001602078 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-07-17
Fiscal Year End
Jul 17, 2023
Accession No.
0001079973-23-000973
Primary Document
nmra_10k-033123.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001602078 · Accession 0001079973-23-000973

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2024-02-12
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2024-09-26Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2024-09-26
View
DEF 14CDEF 14C
DEFINITIVE 14C
2024-07-01
View
NT 10-KNT 10-K
FORM 12B-25
2024-07-01
View
8-KCurrent Report
FORM 8-K
2024-05-17
View
8-KCurrent Report
FORM 8-K
2024-04-22
View
PRE 14CPRE 14C
PRE 14C
2024-04-19
View
8-KCurrent Report
FORM 8-K
2024-04-10
View
25-NSE25-NSE
25-NSE
2024-03-21
View
8-KCurrent Report
FORM 8-K
2024-02-26
View
SC 13GBeneficial Ownership Report
Beneficial Ownership Report
2024-02-14
View
10-QQuarterly Report
FORM 10-Q
2024-02-12
View
DEFA14AProxy Statement (Additional)
DEFINITIVE 14A ADDTIONAL MATERIALS
2024-01-17
View
DEF 14AProxy Statement
DEFINITIVE 14A
2024-01-17
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2024-01-09
View
8-KCurrent Report
FORM 8-K
2024-01-03
View
Showing 1–15 of 263 filingsForm 4 / 144 hidden· 276 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001602078  |  Exchange: OTC · Healthcare

Nemaura Medical Inc. (OTC: NMRD) has submitted 276 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2018. As a Healthcare sector company with CIK 0001602078, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Nemaura Medical Inc.'s most comprehensive regulatory disclosure. The most recent Nemaura Medical Inc. 10-K was filed on 2023-07-17 for fiscal year ending 2023. Historical NMRD 10-K annual reports are available from 2014 through 2023.

Investors researching Nemaura Medical Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
UPH SEC Filings →VICA SEC Filings →REMI SEC Filings →LCDX SEC Filings →BXRXQ SEC Filings →KLDO SEC Filings →CYPS SEC Filings →TNGNQ SEC Filings →
→ NMRD Financials→ NMRD Earnings→ NMRD Insider Trades

Frequently Asked Questions

NMRD SEC Filings · 8 questions

Nemaura Medical Inc. (NMRD) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 276 filings and access original documents at no cost. Nemaura Medical Inc.'s CIK is 0001602078.

NMRD SEC filingsNemaura Medical Inc. SEC documentsfind NMRD 10-K